GTBP / GT Biopharma, Inc. - Net Long/Short Value

GT Biopharma, Inc.
US ˙ NasdaqCM ˙ US36254L2097

GTBP / GT Biopharma, Inc. - Net Long/Short Value
Den här sidan ger nettovärderingarna långa/korta för varje institutionellt innehav som rapporterats via 13F- eller NPORT-anmälningar. För att beräkna nettolångt/kortt värde adderar vi aktievärdet till köpoptionsvärdet och subtraherar säljoptionsvärdet. Fonder som rapporterar kortlånade positioner kommer att rapportera aktievärden som negativa. Långa nettopositioner kommer att ha positiva siffror i kolumnen netto lång/kort, och korta nettopositioner kommer att ha negativa värden i den kolumnen.
Ägare Eget kapitalvärde
($1000)
Call värde
($1000)
Put värde
($1000)
Net Long/Short
($1000)
Wells Fargo & Company/mn
VEXMX - VANGUARD INDEX FUNDS - Vanguard Extended Market Index Fund Investor Shares
FSMAX - FIDELITY CONCORD STREET TRUST - Fidelity Extended Market Index Fund
Bank Of America Corp /de/
Blue Bell Private Wealth Management, Llc
Mount Yale Investment Advisors, LLC
Bnp Paribas Arbitrage, Sa
Vanguard Group Inc
FCFMX - FIDELITY CONCORD STREET TRUST - Fidelity Series Total Market Index Fund
Morgan Stanley
BlackRock, Inc.
Advisor Group Holdings, Inc.
Jpmorgan Chase & Co
Front Row Advisors LLC
UBS Group AG
FSKAX - FIDELITY CONCORD STREET TRUST - Fidelity Total Market Index Fund
Newbridge Financial Services Group, Inc.
Geode Capital Management, Llc
DFSU - Dimensional ETF Trust - Dimensional US Sustainability Core 1 ETF
Tower Research Capital LLC (TRC)
SBI Securities Co., Ltd.
Guggenheim Active Allocation Fund
Bank Of Montreal /can/
Allworth Financial LP
Hartland & Co., LLC
Jones Financial Companies Lllp
Renaissance Technologies Llc
Other Listings
DE:OXIA
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista